34.95
0.03 (0.09%)
| Previous Close | 34.92 |
| Volume | 863,320 |
| Price / Earnings (Forward) | 217.39 |
| Price / Sales | 16.22 |
| Price / Book | 4.07 |
| 52 Weeks Range |
| Profit Margin | -11.86% |
| Operating Margin (TTM) | -5.09% |
| Diluted EPS (TTM) | -0.190 |
| Quarterly Revenue Growth (YOY) | 29.90% |
| Total Debt/Equity (MRQ) | 7.64% |
| Current Ratio (MRQ) | 4.73 |
| Operating Cash Flow (TTM) | 14.63 M |
| Levered Free Cash Flow (TTM) | 39.10 M |
| Return on Assets (TTM) | -0.79% |
| Return on Equity (TTM) | -2.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | BioLife Solutions, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -5.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Average | -1.00 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 2.84% |
| % Held by Institutions | 100.53% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BERARD TODD | - | 35.38 | -356 | -12,595 |
| MATHEW ABY J. | - | 35.38 | -627 | -22,183 |
| WICHTERMAN TROY | - | 35.38 | -1,026 | -36,300 |
| Aggregate Net Quantity | -2,009 | |||
| Aggregate Net Value ($) | -71,078 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 35.38 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MATHEW ABY J. | Officer | 08 Sep 2026 | Disposed (-) | 627 | 35.38 | 22,183 |
| WICHTERMAN TROY | Officer | 08 Sep 2026 | Disposed (-) | 1,026 | 35.38 | 36,300 |
| BERARD TODD | Officer | 08 Sep 2026 | Disposed (-) | 356 | 35.38 | 12,595 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |